{"title":"用于诊断阿尔茨海默病的放射性药物的毒性问题。","authors":"Shristy Verma, Rishabha Malviya, Sathvik Belagodu Sridhar","doi":"10.2174/0118715249340822240828065449","DOIUrl":null,"url":null,"abstract":"<p><p>This editorial discusses the toxicity and ethical concerns associated with the utilization of radiopharmaceuticals for diagnosing Alzheimer's disease. It highlights the potential benefits of using amyloid tracers during the early stages of diagnosing the disease. However, it also raises ethical concerns regarding the communication of this data to patients as well as their families. Additionally, it addresses the toxicity concerns associated with different radiopharmaceuticals, elucidating their potential to accumulate in bone and pose risks to the kidneys and bone marrow. We have examined the negative consequences, such as blood-related toxicity and suppression of bone marrow function, which have been recorded for different radiopharmaceuticals.</p>","PeriodicalId":93930,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Toxicity Concern for the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.\",\"authors\":\"Shristy Verma, Rishabha Malviya, Sathvik Belagodu Sridhar\",\"doi\":\"10.2174/0118715249340822240828065449\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This editorial discusses the toxicity and ethical concerns associated with the utilization of radiopharmaceuticals for diagnosing Alzheimer's disease. It highlights the potential benefits of using amyloid tracers during the early stages of diagnosing the disease. However, it also raises ethical concerns regarding the communication of this data to patients as well as their families. Additionally, it addresses the toxicity concerns associated with different radiopharmaceuticals, elucidating their potential to accumulate in bone and pose risks to the kidneys and bone marrow. We have examined the negative consequences, such as blood-related toxicity and suppression of bone marrow function, which have been recorded for different radiopharmaceuticals.</p>\",\"PeriodicalId\":93930,\"journal\":{\"name\":\"Central nervous system agents in medicinal chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Central nervous system agents in medicinal chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0118715249340822240828065449\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central nervous system agents in medicinal chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118715249340822240828065449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Toxicity Concern for the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.
This editorial discusses the toxicity and ethical concerns associated with the utilization of radiopharmaceuticals for diagnosing Alzheimer's disease. It highlights the potential benefits of using amyloid tracers during the early stages of diagnosing the disease. However, it also raises ethical concerns regarding the communication of this data to patients as well as their families. Additionally, it addresses the toxicity concerns associated with different radiopharmaceuticals, elucidating their potential to accumulate in bone and pose risks to the kidneys and bone marrow. We have examined the negative consequences, such as blood-related toxicity and suppression of bone marrow function, which have been recorded for different radiopharmaceuticals.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
